Related references
Note: Only part of the references are listed.Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levels
Nehad M. Ayoub et al.
INVESTIGATIONAL NEW DRUGS (2021)
Stabilization of fatty acid synthesis enzyme acetyl-CoA carboxylase 1 suppresses acute myeloid leukemia development
Hidenori Ito et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Phase Ib Study of Crizotinib Plus Pembrolizumab in Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer with ALK Translocation
Sandip Pravin Patel et al.
ONCOLOGIST (2020)
The clinical efficacy of combinatorial therapy of EGFR-TKI and crizotinib in overcoming MET amplification-mediated resistance from prior EGFR-TKI therapy
Yubo Wang et al.
LUNG CANCER (2020)
Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib
Abhishek Tripathi et al.
CLINICAL CANCER RESEARCH (2020)
Dopamine receptor antagonists induce differentiation of PC-3 human prostate cancer cell-derived cancer stem cell-like cells
Su In Lee et al.
PROSTATE (2019)
Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell death
Peng Liu et al.
ONCOIMMUNOLOGY (2019)
Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Peng Liu et al.
NATURE COMMUNICATIONS (2019)
E-cadherin is required for metastasis in multiple models of breast cancer
Veena Padmanaban et al.
NATURE (2019)
(S)-crizotinib reduces gastric cancer growth through oxidative DNA damage and triggers pro-survival akt signal
Jiansong Ji et al.
CELL DEATH & DISEASE (2018)
Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells
Francis O. Enane et al.
CELL DEATH & DISEASE (2018)
Suppression of cancer stem-like phenotypes in NCI4-1460 lung cancer cells by vanillin through an Akt-dependent pathway
Songpol Srinual et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
(S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1
Xuanxuan Dai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
Daniel Garcia et al.
MOLECULAR CELL (2017)
Reactive oxygen species mediate soft corals-derived sinuleptolide-induced antiproliferation and DNA damage in oral cancer cells
Yung-Ting Chang et al.
ONCOTARGETS AND THERAPY (2017)
Monoclonal antibodies against autocrine motility factor suppress gastric cancer
Hahn-Sun Jung et al.
ONCOLOGY LETTERS (2017)
Acetyl-CoA Carboxylase 1-Dependent Protein Acetylation Controls Breast Cancer Metastasis and Recurrence
Marcos Rios Garcia et al.
CELL METABOLISM (2017)
EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1 alpha and STAT3
Jaemoon Koh et al.
ONCOIMMUNOLOGY (2016)
HDAC Inhibitor Oxamflatin Induces Morphological Changes and has Strong Cytostatic Effects in Ovarian Cancer Cell Lines
Y. -L. Wang et al.
CURRENT MOLECULAR MEDICINE (2016)
E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition
Augustine Chen et al.
BMC CANCER (2014)
HIP1-ALK, A Novel ALK Fusion Variant that Responds to Crizotinib
Douglas D. Fang et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy
Kilian V. M. Huber et al.
NATURE (2014)
Maintenance of the stemness in CD44+ HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression
Sy-Yeuan Ju et al.
STEM CELL RESEARCH (2014)
AMPK Knockdown in Placental Trophoblast Cells Results in Altered Morphology and Function
Erica A. K. Carey et al.
STEM CELLS AND DEVELOPMENT (2014)
Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics
BreeAnn N. Brandhagen et al.
BMC CANCER (2013)
The Role of Snail in EMT and Tumorigenesis
Yifan Wang et al.
CURRENT CANCER DRUG TARGETS (2013)
Cadherin junctions and their cytoskeleton(s)
William M. Brieher et al.
CURRENT OPINION IN CELL BIOLOGY (2013)
E-cadherin-integrin crosstalk in cancer invasion and metastasis
Marta Canel et al.
JOURNAL OF CELL SCIENCE (2013)
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
Kristin Bergethon et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
Crizotinib-Resistant Mutants of EML4-ALK Identified Through an Accelerated Mutagenesis Screen
Sen Zhang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
J. Jean Cui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
Elaine Lai-Han Leung et al.
PLOS ONE (2010)
Overexpression of E-cadherin on Melanoma Cells Inhibits Chemokine- promoted Invasion Involving p190RhoGAP/p120ctn-dependent Inactivation of RhoA
Isabel Molina-Ortiz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma
James G. Christensen et al.
MOLECULAR CANCER THERAPEUTICS (2007)
ROS up-regulatlion mediates Ras-induced changes of cell morphology and motility
Antonina Y. Alexandrova et al.
EXPERIMENTAL CELL RESEARCH (2006)
Share Paper
